H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Jazz Pharmaceuticals, Inc. | 4 | $180,000 | $136,000 - $265,000 | 100.0% |
| NOVARTIS PHARMACEUTICALS CORPORATION | 3 | $124,405 | $124,322 - $167,814 | 100.0% |
| BRISTOL-MYERS SQUIBB COMPANY | 2 | $271,087 | $267,081 - $275,093 | 100.0% |
| Leap Therapeutics Inc. | 2 | $202,500 | $195,000 - $210,000 | 100.0% |
| GERON CORPORATION | 2 | $222,719 | $205,000 - $240,437 | 100.0% |
| JUNO THERAPEUTICS INC. | 2 | $253,900 | $250,000 - $257,800 | 100.0% |
| ITI, Inc. | 2 | $186,430 | $182,770 - $190,090 | 100.0% |
| PepGen Inc. | 1 | $255,000 | $255,000 - $255,000 | 100.0% |
| Pfizer Inc. | 1 | $150,900 | $150,900 - $150,900 | 100.0% |
| Quidel Corporation | 1 | $155,000 | $155,000 - $155,000 | 100.0% |
| Sarepta Therapeutics, Inc. | 1 | $250,000 | $250,000 - $250,000 | 100.0% |
| Teva Branded Pharmaceutical Products R&D, Inc. | 1 | $190,026 | $190,026 - $190,026 | 100.0% |
| Alexion Pharmaceuticals, Inc. | 1 | $228,800 | $228,800 - $228,800 | 100.0% |
| Vanda Pharmaceuticals, Inc | 1 | $230,000 | $230,000 - $230,000 | 100.0% |
| AXIO RESEARCH LLC | 1 | $142,800 | $142,800 - $142,800 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Director | 26 | $207,500 | $124,322 - $275,093 |
| Principal | 2 | $136,000 | $136,000 - $136,000 |
| Senior | 2 | $121,767 | $113,534 - $130,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Seattle | WA | 5 | $257,800 |
| Cambridge | MA | 4 | $215,000 |
| Boston | MA | 2 | $241,900 |
| Parsippany | NJ | 2 | $222,719 |
| East Hanover | NJ | 2 | $146,110 |
| Bedminster | NJ | 2 | $186,430 |
| Pasadena | CA | 1 | $130,000 |
| Philadelphia | PA | 1 | $136,000 |
| San Diego | CA | 1 | $155,000 |
| San Francisco | CA | 1 | $113,534 |
These roles are variations of Director, Biostatistics with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Director, Biostatistics | 39 | $192,715 | |
| BIOMETRICIAN BIOSTATISTICS | Unspecified | 10 | $82,143 |
| Senior Biostatistics Analyst(Real World Data&Adv.Analitics) | 3 | $102,500 | |
| SR BIOMETRICIAN BIOSTATISTICS | 2 | $90,775 | |
| Principal Biostatistics | 2 | $136,000 | |
| Principal Biostatistician,Biostatistics and Pharmacometrics | 1 | $118,220 | |
| Senior Biostatistician, Oncology Biostatistics | 1 | $108,000 | |
| Senior Principal Biostatistician, Early Clinical Biostatistics | 1 | $125,338 | |
| Senior Principal Biostatistician, Oncology Global Development Biostatistics | 1 | $124,484 | |
| Senior Biostatistics Analyst(Real World Data&Adv.Analytics) | 1 | $130,000 | |
| Sr. Biostatistics 586.202 | 1 | $113,534 | |
| Principal Biostatistician, Biomarkers and Diagnostics Biostatistics | 1 | $120,640 | |
| Principal Biostatistician, Biostatistics | 1 | $114,668 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 6 | $177,500 | 100.0% |
| 2022 | 8 | $146,850 | 100.0% |
| 2023 | 4 | $232,500 | 100.0% |
| 2024 | 4 | $243,900 | 100.0% |
| 2025 | 5 | $190,090 | 100.0% |
| 2026 | 3 | $195,000 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Jazz Pharmaceuticals, Inc. | 4 | $180,000 | 100.0% |
| NOVARTIS PHARMACEUTICALS CORPORATION | 3 | $124,405 | 100.0% |
| BRISTOL-MYERS SQUIBB COMPANY | 2 | $271,087 | 100.0% |
| Leap Therapeutics Inc. | 2 | $202,500 | 100.0% |
| GERON CORPORATION | 2 | $222,719 | 100.0% |